Spark raises $350M in follow-on

On Aug. 3, gene therapy company Spark Therapeutics Inc. (NASDAQ:ONCE) raised $350 million through the sale of 4.6 million shares at $76 in a follow-on underwritten by JPMorgan, Goldman Sachs and Cowe...